Difference in TFPI Levels Between Haemophilia A and B Patients
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Tissue factor pathway inhibitor is a potential modifier of bleeding risk in factor XI deficiency.
Reitsma S, Holle L, Bouck E, Monroe D, Mast A, Burthem J J Thromb Haemost. 2023; 21(3):467-479.
PMID: 36696199 PMC: 10111213. DOI: 10.1016/j.jtha.2022.10.005.
Ellery P, Hilden I, Thyregod P, Martinez N, Maroney S, Gill J Haemophilia. 2019; 25(6):1083-1091.
PMID: 31608540 PMC: 6995352. DOI: 10.1111/hae.13860.